Drug profile · INN
revumenib citrate
REVUFORJ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
revumenib citrate (REVUFORJ) is an FDA-listed pharmaceutical active ingredient. Associated with Syndax Pharmaceuticals Inc. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN revumenib citrate
Brand REVUFORJ
Route ORAL
Formulation TABLET
Originator Syndax Pharmaceuticals Inc
Frequently asked questions
What is revumenib citrate?
revumenib citrate (REVUFORJ) is an FDA-listed pharmaceutical active ingredient. Associated with Syndax Pharmaceuticals Inc. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for revumenib citrate?
REVUFORJ is a marketed brand name for revumenib citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of revumenib citrate?
revumenib citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.